PetIQ, Inc. (PETQ) Tops Q4 EPS by 12c, Revs In-Line
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Anthropic and Accenture partner on embedded AI safety evaluation
PetIQ, Inc. Reports Fourth Quarter and Full Year 2017 Financial Results
March 13, 2018 4:05 PM EDTEAGLE, Idaho, March 13, 2018 (GLOBE NEWSWIRE) -- PetIQ, Inc. (PetIQ or the Company) (NASDAQ: PETQ), a leading pet medication and wellness company, today reported financial results for its fourth quarter and year ended December 31, 2017.
Fourth Quarter 2017 Highlights Compared to Prior Year Period
Net sales were $51.9 million, an increase of 15.6% year-over-yearNet loss was $3.4 millionAdjusted net income increased $3.7 million to $2.6 millionAdjusted EBITDA increased $2.0 million to $3.6 million, an increase of 132% year-over-yearFull Year 2017 Highlights Compared to Prior Year
Net sales were $266.7 million, an increase of 33.2%... More